Qiong Wang
7PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 28, 2026
A first-in-class small-molecule inhibitor targeting AVIL exhibits safety and antitumor efficacy in preclinical models of glioblastoma.Zhongqiu Xie, Pawel Ł Janczyk, Robert Cornelison
|Sep 22, 2025
Induction of ferroptosis in prostate cancer by CCDC719-13 via TRIM21-mediated ubiquitination of SLC7A11.Bisheng Cheng, Qiong Wang, Zean Li
|Apr 16, 2025
Profiling chimeric RNA in prostate cancer in Chinese cohorts reveals similarities and differences compared to Western populations.Qiong Wang, Shunli Yu, Jirong Jie
|Nov 14, 2024
Chimeric SFT2D2-TBX19 Promotes Prostate Cancer Progression by Encoding TBX19-202 Protein and Stabilizing Mitochondrial ATP Synthase through ATP5F1A Phosphorylation.Chenxi Hu, Zaosong Zheng, Shiyu Pang
|Jan 15, 2024
A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3.Qiong Wang, Bisheng Cheng, Sandeep Singh
|May 05, 2023
Rhabdomyosarcomas are oncogene addicted to the activation of AVIL.Zhongqiu Xie, Pawel L Janczyk, Xinrui Shi
Pageof 2
Frequent Collaborators
5 joint publications
Hui Li
3 joint publications
Hai Huang
2 joint publications
Zhongqiu Xie
2 joint publications
Sandeep Singh
2 joint publications
Yiwei Wang
1 joint publications
Mujun Lu
1 joint publications
James W Mandell
1 joint publications
Frederic G Barr
1 joint publications
Fujun Qin
1 joint publications
Xu Gao
